NorthWest Biotherapeutics Inc (NWBO)

[TZOR]

So if we assume L receives approval, if the P/E was 25, to sustain a 2 billion market cap we would need 80 million in earnings. If the patient's procedure cost 100K with a 30% profit margin, we would need 2,667 patients annually. There are a lot of variables in that calculation, it's just a rough estimate.

I recall (loose recollection) USA has 12k diagnosed GBM's per year, and Europe has 10K per year. Let's assume 22K GBM's per year, at 2,667 patients a year is a 12% market penetration.